期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性ST段抬高型心肌梗死再灌注治疗的急缓之择 被引量：5

Balance the Emergency or Delay Treatment in Reperfusion Strategies for Acute ST-segment Elevation Myocardial Infarction
下载PDF
导出
摘要 急性ST段抬高型心肌梗死(STEMI)最有效治疗方法是再灌注治疗,主要包括直接经皮冠状动脉介入治疗(PCI)和溶栓治疗。只有结合患者、医疗机构的实际情况,合理选择再灌注治疗方案,才能使STEMI患者获益最大化,改善其长期预后。 Reperfusion is the most efficient treatment for acute ST--segment elevation myocardial infarction （STEMI）. Reperfusion mainly includes primary percutaneous coronary intervention（PCI） and fibrinolysis treatment. It is best to combine the conditions of patients and the hospital--level factor to select the optimal reperfusion strategies, which could extend benefits and improve long--terra outcomes for STEMI patients.
作者 刘海伟 韩雅玲
机构地区 沈阳军区总医院心内科
出处 《医学与哲学（B）》 2012年第1期44-45,共2页 Medicine & Philosophy(B)
关键词 ST段抬高型心肌梗死 再灌注治疗 经皮冠状动脉介入治疗 溶栓治疗 ST-- segment elevation myocardial infarction, reperfusion strategies, percutaneous coronary intervention, fibrinolysis treatment
分类号 R542.22 [医药卫生—心血管疾病]
  • 相关文献

参考文献11

  • 1中华医学会心血管病学分会 中华心血管病杂志编辑委员会.急性sT段抬高型心肌梗死诊断和治疗指南.中华心血管病杂志,2010,:675-675.
  • 2Frederick G K,Mary H, Sidney C S, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-- Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percu- taneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) : A Report of the American College of Cardi- ology Foundation/American Heart Association Task Force on Prac- tice Guidelines[J]. JACC,2009,54(23) :2205--2241.
  • 3Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial re- vascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Asso- ciation for Cardio--Thoracic Surgery (EACTS)[J]. Eur Heart J, 2010,31(20) :2501--2555.
  • 4沈珑,何奔.溶栓后PCI,从不行到可行[J].医学与哲学（B）,2010,31(10):35-36. 被引量：3
  • 5刘刚,陈彧,胡大一.2010版欧洲心肌再血管化指南解读[J].医学与哲学（B）,2010,31(12):16-20. 被引量：3
  • 6Pinto D S, Kirtane A J, Nallamothu B K, et al. Hospital delays in reperfusion for ST--elevation myocardial infarctions implications when selecting reperfusion strategy [J]. Circulation, 2006, 114 (19) : 2019-2025.
  • 7杨艳敏,朱俊,谭慧琼,梁岩,章晏,李建东,刘力生,CREATE中国课题组.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176-2182. 被引量：86
  • 8Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-- 4 PCI) in- vestigators. Primary versus tenecteplase--facilitated percutaneous coronary intervention in patients with ST--segment elevation acute myocardial infarction (ASSENT--4 PCI): randomised trial[J]. Lancet,2006,367(9510) :569--578.
  • 9Keeley E C,Boura .] A, Grines C L. Comparison of primary and fa cilitated percutaneous coronary interventions for ST--elevation my ocardial infarction: quantitative review of randomised trials [J] Lancet,2006,367 (9510) :579--588.
  • 10Gershlick A H,Stephens--Lloyd A, Hughes S, et al. Rescue an- gioplasty after failed thrombolytic therapy for acute myocardial in- farction[J]. N Engl J Med,2005,353(26) :2758--2768.

二级参考文献21

  • 1谭慧琼,朱俊,梁岩,章晏,刘力生,代表OASIS登记试验中国地区协作组.非ST段抬高的急性冠状动脉综合征二年随访[J].中华医学杂志,2005,85(3):184-188. 被引量：12
  • 2陈韵岱,宋现涛,吕树铮,朱华刚,潘伟琦,宁尚秋,康铁朵.12小时内就诊的急性心肌梗死患者治疗现状分析[J].中国介入心脏病学杂志,2005,13(1):5-8. 被引量：67
  • 3梁岩,朱俊,谭慧琼,李建冬,刘力生,OASIS登记试验中国地区协作组.中国地区非ST抬高急性冠脉综合征患者生存时间的影响因素分析[J].中华医学杂志,2005,85(13):873-878. 被引量：18
  • 4杨艳敏,朱俊,谭慧琼,梁岩,章晏,李建东,刘力生,CREATE中国课题组.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176-2182. 被引量：86
  • 5于丽天,朱俊,Rebecca Mister,章晏,李建冬,王多劳,刘力生,Marcus Flather.我国部分医院ST段抬高急性冠状动脉综合征再灌注治疗登记研究[J].中华心血管病杂志,2006,34(7):593-597. 被引量：30
  • 6Keeley E C, Boura J A, Grines versus intravenous thrombolytic C L, et al. Primary angioplasty therapy for acute myocardial in farction: a quantitative review of 23 randomised trials[J]. Lancet 2003,361(9351):13-20.
  • 7Fassa A A, Urban P, Radovanovic D, et al. AMIS Plus Investigators. Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry[J]. Heart, 2005, 91: 882-888.
  • 8Fox K A,Goodman S G,Anderson F A Jr, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes[J]. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J,2003,24: 1414-1424.
  • 9Hasdai D,Behar S,Wallentin L,ct al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro heart survey ACS) [J]. Eur Heart 1,2002.23. 1190-1201.
  • 10饶克勤.中国卫生统计年鉴2005[M].北京:协和医科大学出版社,2006:3-15.

共引文献141

同被引文献37

  • 1刘永岭,张厚亮,刘建军,Mahande,王佩显.左心功能不全患者超声参数与血浆NT-proBNP的关系[J].放射免疫学杂志,2007,20(1):80-82. 被引量：3
  • 2Santoro G M,Carrabba N,Migliorini A,et al. Acute heart failure in pa- tients with acute myocardial infarction treated with primary percutane- ous coronary intervention[J]. Eur J Heart Fail,2008,10(8) :780-785.
  • 3Bassan R, Potsch A, Maisel A, et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation[J]. Eur Heart J, 2005,26(3) :234 -240.
  • 4Potocki M, Mair J, Weber M, et al. Relation of N-terminal pro-B- type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation[J]. Am J Cardiol, 2009,104(4) : 559- 564.
  • 5Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorvastatin re- load in patients on chronic statin undergoing percutaneous coronary intervention : results of the ARMYDA-RECAPTURE( Atorvastatin for Reduction of Myocardial Damage During Angioplasty)Random- ized Trial [J]. J Am Coil Cardiol,2009,54(6) :558-565.
  • 6Briguori C,Visconti G, Focaccio A, et al. Novel approaches for pre- venting or limiting events (NAPLES) Ⅱ trial:impact of a sigle high loading dose of atorvastatin on periprocedural myocardial infarction [J]. J Am Coil Cardio1,2009,54(23) :2157-2163.
  • 7Foody J M, Shah R, Galusha D, et al. Statins and mortality among elderly patients hospitalized with heart failure [J]. Circulation, 2006,113(8):1086-1092.
  • 8Feldman A M,Combes A,Wagner D,et al. The role of tumor necro sis factor in the pathophysiology of heart failure[J]. J Am Coll Car diol, 2000,35 (3) : 537- 544.
  • 9Skayian Y,Kreydiyyeh S I. Tumor necrosis factor alpha alters Na+ - K+ ATPase activity in rat cardiac myocytes: Involvement of NF- kappa B,AP-1 and PGE2[J]. Life Sci,2006,80(2):173-180.
  • 10Strey C H, Young M, Molyneux S L, et al. Endothelium-ameliora ting effects of statin therapy and coenzyme Q10 reductions in chron- ic heart failure[J]. Atheroselerosis, 2005,179 ( 1 ) : 201 - 206.

引证文献5

二级引证文献7

医学与哲学（B）
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部